We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
(+14%)
Cap. Flow
+$7.27B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.04B |
| 2 |
Microsoft
MSFT
|
+$830M |
| 3 |
Amazon
AMZN
|
+$550M |
| 4 |
Johnson & Johnson
JNJ
|
+$483M |
| 5 |
Apple
AAPL
|
+$470M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$435M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$428M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$371M |
| 5 |
Micron Technology
MU
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 13.75% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 7.81% |
| 5 | Industrials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Ryder
R
$9.82B
| $2.97M | ﹤0.01% |
23,952
+21,009
| +714% | +$2.54M |
|
|
LSXMK
1177
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $2.95M | ﹤0.01% |
133,348
-146,038
| -52% | -$3.47M |
|
1178
Rapid7
RPD
$637M
| $2.95M | ﹤0.01% |
68,354
+54,054
| +378% | +$2.25M |
|
1179
Ocular Therapeutix
OCUL
$1.85B
| $2.94M | ﹤0.01% |
+429,592
| New | +$2.65M |
|
1180
Celanese
CE
$4.78B
| $2.94M | ﹤0.01% |
+21,770
| New | +$3.33M |
|
1181
Axcelis
ACLS
$3.51B
| $2.94M | ﹤0.01% |
20,651
-62,217
| -75% | -$7.17M |
|
1182
Olin
OLN
$2.48B
| $2.93M | ﹤0.01% |
+62,130
| New | +$3.32M |
|
|
MTTR
1183
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $2.92M | ﹤0.01% |
653,639
-372,174
| -36% | -$1.41M |
|
1184
Semtech
SMTC
$9.86B
| $2.92M | ﹤0.01% |
97,675
-50,628
| -34% | -$1.77M |
|
1185
AvalonBay Communities
AVB
$27.4B
| $2.9M | ﹤0.01% |
14,005
-284,913
| -95% | -$55.1M |
|
1186
BioNTech
BNTX
$23.4B
| $2.89M | ﹤0.01% |
+35,985
| New | +$3.29M |
|
1187
AvePoint
AVPT
$2.76B
| $2.88M | ﹤0.01% |
+276,487
| New | +$2.4M |
|
|
FARO
1188
DELISTED
Faro Technologies
FARO
| $2.87M | ﹤0.01% |
179,651
-79,069
| -31% | -$1.47M |
|
1189
ATI
ATI
$24.4B
| $2.85M | ﹤0.01% |
51,408
+41,367
| +412% | +$2.32M |
|
|
SLN
1190
Silence Therapeutics
SLN
$539M
| $2.84M | ﹤0.01% |
149,397
+10,206
| +7% | +$217K |
|
|
DO
1191
DELISTED
Diamond Offshore Drilling, Inc.
DO
| $2.83M | ﹤0.01% |
182,907
-1,815,617
| -91% | -$25.9M |
|
1192
Hawaiian Electric Industries
HE
$2.26B
| $2.83M | ﹤0.01% |
313,255
+154,116
| +97% | +$1.6M |
|
1193
Veeco
VECO
$2.67B
| $2.8M | ﹤0.01% |
59,986
+14,991
| +33% | +$592K |
|
1194
Dianthus Therapeutics
DNTH
$5.58B
| $2.8M | ﹤0.01% |
108,199
-4,731
| -4% | -$114K |
|
1195
Inhibrx
INBX
$1.15B
| $2.8M | ﹤0.01% |
+197,500
| New | +$3.09M |
|
1196
MacroGenics
MGNX
$236M
| $2.8M | ﹤0.01% |
658,007
+621,232
| +1,689% | +$6.05M |
|
|
NOA
1197
North American Construction
NOA
$365M
| $2.79M | ﹤0.01% |
144,838
+30,535
| +27% | +$636K |
|
1198
Red Robin
RRGB
$139M
| $2.79M | ﹤0.01% |
368,541
+240,954
| +189% | +$1.75M |
|
|
MODV
1199
DELISTED
ModivCare
MODV
| $2.78M | ﹤0.01% |
105,859
+19,648
| +23% | +$497K |
|
1200
CoreCivic
CXW
$2.98B
| $2.78M | ﹤0.01% |
213,880
+108,079
| +102% | +$1.58M |
|
Similar funds
Marshall Wace's Q2 2024 Portfolio in Review
As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.
- Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
- Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
- Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
- Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
- Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.
Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.